Importantly, altered HH signaling as well as the ectopic activation of its effectors, GLI transcription factors, are implicated in multiple types of cancers, most notably in basal cell carcinoma (BCC), medulloblastoma (MB), and rhabdomyosarcoma (reviewed in [1]). This evidence concerns the gene GLI1 and cancer.